Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK

D A Enoch; J A Karas; S H Aliyu

doi:10.1016/j.ijantimicag.2008.10.014

Oral antimicrobial options for the treatment of skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA) in the UK

Int J Antimicrob Agents. 2009 Jun;33(6):497-502. doi: 10.1016/j.ijantimicag.2008.10.014. Epub 2008 Dec 20.

Authors

D A Enoch¹, J A Karas, S H Aliyu

Affiliation

¹ Clinical Microbiology & Public Health Laboratory, Peterborough District Hospital, Thorpe Road, Peterborough PE36JW, UK. [email protected]

PMID: 19101123
DOI: 10.1016/j.ijantimicag.2008.10.014

Abstract

This review outlines the oral treatment options available for treating skin and soft-tissue infections due to methicillin-resistant Staphylococcus aureus (MRSA) in the community and discusses the evidence supporting their use.

Publication types

Review

MeSH terms

Administration, Oral
Anti-Bacterial Agents / administration & dosage*
Anti-Bacterial Agents / therapeutic use*
Community-Acquired Infections / drug therapy*
Community-Acquired Infections / microbiology
Humans
Methicillin-Resistant Staphylococcus aureus / drug effects*
Methicillin-Resistant Staphylococcus aureus / isolation & purification
Soft Tissue Infections / drug therapy*
Soft Tissue Infections / microbiology*
Staphylococcal Skin Infections / drug therapy*
United Kingdom

Substances

Anti-Bacterial Agents